China Healthwise Holdings Limited (China Healthwise, HKEX: 00348) has released its 2025 Environmental, Social and Governance (ESG) Report, setting absolute targets to keep greenhouse-gas (GHG) emission intensity, energy-consumption intensity, water-consumption intensity and waste-generation intensity “stable” through 2035 while strengthening board-level climate oversight.
Key environmental metrics for 2025 • No direct (Scope 1) emissions were recorded as the Group operated without company vehicles during the year. • Indirect (Scope 2) emissions totalled 124 tonnes of CO₂-e, broadly unchanged from 119 tonnes in 2024. • Electricity consumption rose to 308 MWh from 293 MWh; energy intensity reached 4.05 MWh per employee versus 3.67 MWh a year earlier. • Water consumption climbed to 128 m³ (1.68 m³ per employee) from 101 m³. • Non-hazardous waste generation increased to 0.29 tonnes (0.004 tonnes per employee); hazardous waste remained nil. • Packaging materials usage declined slightly to 9.2 tonnes, comprising 4.9 tonnes of paper, 3.1 tonnes of plastic and 1.2 tonnes of metal.
Governance and climate resilience • An ESG Working Group—two executive directors, an assistant HR manager and an accountant—reports directly to the board and meets annually to review ESG risks, including climate change. • Scenario analysis references International Energy Agency 2 °C and “beyond 2 °C” cases; planned actions include a natural-disaster emergency plan and expanded renewable-energy use. • The Group is developing Scope 3 emissions mapping for future disclosure.
Workforce profile and safety • Headcount stood at 76 (43 % male, 57 % female); turnover rate fell to 20 % from 31 %. • Three work-related injuries were recorded (131 lost days) with zero fatalities. • Health-and-safety training is mandatory for all staff; no material breaches of safety regulations were reported.
Human capital development • Twenty-five per cent of employees received training, averaging 2.4 hours per capita; senior management averaged 9.5 hours. • Employee benefits include mandatory provident fund contributions, medical insurance, social insurance and statutory leave.
Ethics and supply chain • No corruption cases were recorded; 10 employees, including all eight directors, completed anti-corruption training totalling 10 hours. • The Group engaged 22 Hong Kong-based suppliers and conducts periodic performance and compliance reviews.
Product responsibility • Nam Pei Hong, the Group’s Chinese health-products arm, maintained Hong Kong Tourism Board Quality Tourism Services accreditation for the 15th-19th consecutive year and holds “Hong Kong Top Brand” status. • No product recalls or customer complaints were reported in 2025; intellectual-property safeguards remain in force under the “No Fakes Pledge Scheme.”
Community engagement • The Group continued to participate in local community activities, donations and scholarship initiatives, integrating social participation into business development.
The full ESG report covers the Chinese health-products, money-lending and financial-investment segments in Hong Kong and mainland China for the period 1 January–31 December 2025.